Categories AlphaGraphs, Earnings, Health Care
Earnings: Highlights of Eli Lilly’s (LLY) Q3 2022 results
Eli Lilly and Company (NYSE: LLY) on Tuesday reported higher earnings and revenues for the third quarter of 2022. The company also provided guidance for fiscal 2022.
The Indianapolis-based pharmaceutical company said its revenues moved up 2% year-over-year to $6.94 billion in the third quarter as worldwide volumes increased by 13%.
The positive top-line performance translated into a 12% increase in net earnings, on an adjusted basis, to $1.98 per share. Unadjusted profit increased to $1.45 billion or $1.61 per share from $1.11 billion or $1.22 per share in the third quarter of 2021.
Check this space to read management/analysts’ comments on Eli Lilly’s Q3 2022 earnings
“With four more launches expected by the end of next year and a potential major new indication for tirzepatide, Lilly continues to make progress for patients with unaddressed medical needs through our significant commitment to invest in R&D, welcome the best talent, and turn breakthroughs in our labs into medicines for people around the world,” said David Ricks, CEO of Eli Lilly.
Prior Performance
Most Popular
Key highlights from Deere & Co.’s (DE) Q4 2024 earnings results
Deere & Company (NYSE: DE) reported its fourth quarter 2024 earnings results today. Worldwide net sales and revenues decreased 28% year-over-year to $11.14 billion. Net income was $1.24 billion, or
NVDA Earnings: Nvidia Q3 profit jumps, beats estimates
NVIDIA Corporation (NASDAQ: NVDA) on Wednesday reported a sharp increase in adjusted profit and revenue for the third quarter of 2025. Earnings also topped analysts' estimates. The tech firm’s revenues
Lowe’s Companies (LOW): A few points to note about the Q3 2024 performance
Shares of Lowe’s Companies, Inc. (NYSE: LOW) rose over 1% on Wednesday. The stock has gained 8% over the past three months. The company delivered better-than-expected earnings results for the